Loading…
Iovance Biotherapeutics has entered into a lease agreement to build a 136,000 square foot commercial-scale production facility at the Philadelphia Navy Yard for TIL cancer therapies. The company expects to invest approximately $75 million over three years and create several hundred jobs.
| Site | Largest | Latest |
|---|---|---|
| Philadelphia, United States | $75.0M | 2019-05-29 |